Alnylam Pharmaceuticals Inc (NAS:ALNY)
$ 265.68 -3.27 (-1.22%) Market Cap: 34.27 Bil Enterprise Value: 33.19 Bil PE Ratio: 0 PB Ratio: 1,062.72 GF Score: 78/100

Alnylam Pharmaceuticals Inc at H C Wainwright Global Investment Conference (Virtual) Transcript

May 24, 2022 / 11:00AM GMT
Release Date Price: $127.05 (-1.95%)
Patrick Ralph Trucchio
H.C. Wainwright & Co, LLC, Research Division - MD of Equity Research & Senior Healthcare Analyst

Hello, everyone, and thank you for joining the H.C. Wainwright 2022 Global Investment Hybrid Conference. My name is Patrick Trucchio, and I'm a senior health care analyst at H.C. Wainwright.

While we're hybrid this year, we're confident we're going to be able to provide value to you with more than 550 companies presenting at this conference in multiple sector tracks.

H.C. Wainwright is a full-service investment bank, dedicated to providing corporate finance strategic advisory and related services to public and private companies across multiple sectors and regions. We have a total 24 publishing senior analysts in more than 648 companies covered across all sectors.

The in-person venue for the event is the Fountain Blue Hotel in Miami. Virtual participation will be staged simultaneously with over 550 company presentations scheduled as live feed and available on demand. Please join us for one-on-one meetings, corporate presentations and panels that will

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot